Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting

Yiming Jia1, Jingru Li1, Jinfeng Wang1

  • 1Department of Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin City, Heilongjiang Province 150001, China.

Insights

MicroRNA-585-3p (miR-585-3p) is downregulated in ovarian cancer (OC). Restoring miR-585-3p levels inhibits OC cell proliferation and invasion by targeting FSCN1 and the MAPK pathway, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer (OC) is a leading cause of cancer death in women.
  • Dysregulated microRNA (miRNA) expression is implicated in various cancers, including OC.
  • The specific role of miR-585-3p in OC development requires further investigation.

Purpose of the Study:

  • To investigate the biological function and molecular mechanism of miR-585-3p in ovarian cancer.
  • To determine the expression levels of miR-585-3p in OC tissues and cells.
  • To identify target genes and signaling pathways regulated by miR-585-3p in OC.

Main Methods:

  • In vitro cell proliferation, invasion, and migration assays.
  • Bioinformatic screening of miR-585-3p target genes using miRDB.
  • Dual-luciferase reporter assays and Western blot analysis.
  • In vivo animal experiments to assess tumor growth and pathway modulation.

Main Results:

  • miR-585-3p expression is significantly downregulated in OC tissues and cells.
  • Overexpression of miR-585-3p suppressed OC cell proliferation, invasion, and migration.
  • FSCN1 was identified as a direct target of miR-585-3p, and its upregulation in OC was confirmed.
  • miR-585-3p inhibits ERK phosphorylation and blocks the MAPK signaling pathway by targeting FSCN1.
  • In vivo studies confirmed that miR-585-3p inhibits tumor growth via FSCN1 and the MAPK pathway.

Conclusions:

  • miR-585-3p functions as a tumor suppressor in ovarian cancer.
  • The miR-585-3p/FSCN1 axis regulates OC cell behavior and the MAPK signaling pathway.
  • miR-585-3p holds promise as a potential diagnostic biomarker and therapeutic target for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K